[4]Thompson C.J., France A.J., Baylis P.H. Persistent nephrogenic diabetes insipidus following lithium therapy. Scott Med J. 1997;42:16-17. 1
[5]Elboga G., Bulbul F., Unal A., Alpak G., Elboga U., Ozkaya M. Seventy-two months ongoing nephrogenic diabetes insipidus after discontinuation of lithium: a case report. Dusunen Adam J Psychiatry Neurol Sci. 2013398-401.
[6]Guirguis A.F., Taylor H.C. Nephrogenic diabetes insipidus persisting 57 months after cessation of lithium carbonate therapy: report of a case and review of the literature. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2000;6:324-328. 4
[7]Freland L., Beaulieu J.-M. Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front Mol Neurosci. 2012;5:14.
[8]Fenske W., Refardt J., Chifu I., Schnyder I., Winzeler B., Drummond J. A copeptin-based approach in the diagnosis of diabetes insipidus. N Engl J Med. 2018;379:428-439.
[9]Livio F., Wauters J.-P. Intoxication au lithium. Rev Med Suisse. 2000;58:426-430.